31st Mar 2022 12:14
Renalytix PLC - London-based diagnostics company focused on kidney health - Reports a widened pretax loss of USD26.8 million for the six months to December 31, from USD16.2 million a year before. Administrative expenses rise by 96% to USD27.5 million from USD14.0 million, as a result of its "continued growth." Records multiplied revenue of USD1.3 million from USD400,000 on growth in testing volumes. Expects test volumes to grow further as it progresses through the remainder of financial 2022. Read More
